A study to test BI 765179 alone and in combination with ezabenlimab in patients with advanced cancer (solid tumors) and BI 765179 in combination with pembrolizumab in patients with advanced head and neck cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-510307-22-00

Acronym

1463-0001

Enrollment

111

Registered

2024-03-11

Start date

2021-09-24

Completion date

Unknown

Last updated

2025-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced head and neck cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, Czechia, France, Germany, Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026